Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Report 2026

Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Overview

• Chronic Obstructive Pulmonary Disease Virtual Reality Therapy market size has reached to $1.38 billion in 2025 • Expected to grow to $3.33 billion in 2030 at a compound annual growth rate (CAGR) of 19.3% • Growth Driver: Increasing Awareness And Acceptance Of Virtual Reality Therapy Fueling The Growth Of The Market Due To Enhancing Patient Engagement And Wider Adoption • North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market?

Chronic obstructive pulmonary disease virtual reality therapy refers to a non-pharmacological treatment approach that utilizes immersive virtual reality environments to support respiratory rehabilitation, improve lung function, and enhance patient engagement. It combines interactive exercises, breathing techniques, and real-time feedback to help patients manage symptoms and improve overall quality of life. This therapy is increasingly integrated into digital health solutions for home-based and clinical pulmonary care. The main components of chronic obstructive pulmonary disease virtual reality therapy include hardware, software, and services. Hardware refers to virtual reality headsets, sensors, wearables, and related devices used to deliver immersive, interactive therapies that support pulmonary rehabilitation, breathing exercises, and symptom management for chronic obstructive pulmonary disease (COPD) patients. It includes different therapy types such as immersive virtual reality therapy and non-immersive virtual reality therapy, and it finds applications in pulmonary rehabilitation, patient education, pain management, anxiety and stress reduction, and others, serving end-users such as hospitals, clinics, home care settings, and others.

What Is The Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Growth Forecast?

The chronic obstructive pulmonary disease virtual reality therapy market size is expected to see rapid growth in the next few years. It will grow to $3.33 billion in 2030 at a compound annual growth rate (CAGR) of 19.3%. The growth in the forecast period can be attributed to increasing demand for remote respiratory care solutions, rising investments in immersive digital therapeutics, expansion of homecare pulmonary management, growing integration of ai-driven therapy personalization, increasing focus on patient adherence and engagement. Major trends in the forecast period include increasing adoption of home-based vr pulmonary therapy, rising integration of gamified rehabilitation programs, growing use of remote patient monitoring tools, expansion of immersive respiratory training modules, enhanced focus on patient engagement.

Global Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Segmentation

1) By Component: Hardware, Software, Services 2) By Therapy Type: Immersive Virtual Reality Therapy, Non-Immersive Virtual Reality Therapy 3) By Application: Pulmonary Rehabilitation, Patient Education, Pain Management, Anxiety And Stress Reduction, Other Applications 4) By End-User: Hospitals, Clinics, Homecare Settings, Other End-Users Subsegments: 1) By Hardware: Virtual Reality Headsets, Motion Sensors, Haptic Feedback Devices, Wearable Monitors 2) By Software: Pulmonary Rehabilitation Applications, Patient Monitoring Platforms, Data Analytics Tools, Therapy Gamification Software 3) By Services: Remote Pulmonary Therapy, Technical Support, Training And Education, System Integration

What Are The Drivers Of The Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market?

The increasing awareness and acceptance of virtual reality therapy are expected to propel the growth of the chronic obstructive pulmonary disease virtual reality therapy market going forward. Virtual reality therapy refers to the use of immersive virtual reality technology to simulate interactive environments for treatment and rehabilitation. The rise in awareness and acceptance of virtual reality therapy is driven by its proven ability to reduce pain and anxiety, offering patients a non-invasive, drug-free alternative that improves treatment experiences and outcomes. Virtual reality therapy awareness enhances chronic obstructive pulmonary disease (COPD) virtual reality therapy by increasing patient and provider knowledge and promoting the adoption of digital rehabilitation solutions. It improves treatment engagement by familiarizing users with immersive therapy, leading to better adherence and health outcomes. For instance, in July 2024, according to the U.S. Department of Veterans Affairs, a US-based federal government agency, around 3,500 virtual reality (VR) headsets were deployed across more than 170 VA medical centers and outpatient clinics, tripling the number of headsets available for therapeutic use. Therefore, the increasing awareness and acceptance of virtual reality therapy is driving the growth of the chronic obstructive pulmonary disease virtual reality therapy industry. The increasing emphasis on personalized medicine is expected to propel the growth of the chronic obstructive pulmonary disease virtual reality therapy market going forward. Personalized medicine refers to a medical approach that tailors treatment and prevention strategies to an individual’s unique genetic makeup, lifestyle, and environment. The rise of personalized medicine is primarily due to advancements in genomics, which enable precise identification of genetic variations and tailored treatments for individuals. Personalized medicine aids in chronic obstructive pulmonary disease (COPD) virtual reality therapy by tailoring immersive rehabilitation programs to individual patient needs, making treatments more effective and targeted. It improves therapy outcomes by addressing specific symptoms, capabilities, and preferences, enhancing patient engagement and adherence. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. Therefore, the increasing emphasis on personalized medicine is driving the growth of the chronic obstructive pulmonary disease virtual reality therapy industry.

Key Players In The Global Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

Major companies operating in the chronic obstructive pulmonary disease virtual reality therapy market are Inova Health System, Rush University Medical Center, Penumbra Inc., Burke Rehabilitation Hospital, MindMaze SA, XRHealth Inc., Jolly Good Inc., AppliedVR Inc., Carda Health Inc., Lincare Inc., Virtually Better Inc., Wellinks Inc., Breathe Better Rehab, Kivo Health Inc., VRelax B.V., Kaia Health GmbH, Philips Healthcare, ResMed Inc., NuvoAir AB, Cohero Health Inc.

What Are Latest Mergers And Acquisitions In The Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market?

In March 2025, Wellinks Inc., a US-based digital healthcare company, partnered with CareAbout Health to expand virtual-first chronic obstructive pulmonary disease (COPD) management programs within value-based care networks. This partnership aims to improve patient outcomes, reduce hospitalizations, and enhance access to comprehensive, home-based pulmonary care. CareAbout Health is a US-based healthcare management company that supports virtual COPD care programs.

Regional Outlook

North America was the largest region in the chronic obstructive pulmonary disease virtual reality therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market?

The chronic obstructive pulmonary disease virtual reality therapy market consists of revenues earned by entities by providing services such as virtual pulmonary rehabilitation programs, guided breathing and relaxation sessions, remote respiratory therapy, patient education and training modules, tele-rehabilitation support, gamified exercise sessions, and social interaction platforms. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic obstructive pulmonary disease virtual reality therapy market also includes sales of virtual reality (VR) headsets, motion controllers, haptic feedback devices, specialized respiratory training software, cloud-based therapy platforms, and virtual reality (VR)-enabled monitoring systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Report 2026?

The chronic obstructive pulmonary disease virtual reality therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the chronic obstructive pulmonary disease virtual reality therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.